26U vs PY30: Side-by-Side Comparison
Compare 26U (26U) and Galderma Group AG (PY30) side by side: market cap EUR 127.86M vs EUR 42.46B. Financials, growth and model signals on Bullrun.
| Metric | 26U | PY30 |
|---|---|---|
| Company | 26U | Galderma Group AG |
| Country / Exchange | Switzerland · F | Switzerland · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 127.86M | EUR 42.46B |
| P/E ratio | — | 80.4 |
| Dividend yield | — | 0.20% |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 10.80M | EUR 5.24B |
| Revenue growth YoY | +56.6% | +18.0% |
| Net income | EUR -1.42M | EUR 613.00M |
| Gross margin | 26.3% | 68.9% |
| Diluted EPS | -0.28 | 0.52 |